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For approximately 100  yr the eosinophil has been recognized as a  distinct type of 
polymorphonuelear leukocyte (1), but despite an extensive literature, its function re- 
mains largely unknown. An accumulation of eosinophils is evoked by a wide variety of 
immunological responses including anaphylaxis  (2),  immune  complex reactions  (3), 
and  cell-mediated hypersensitivity (4).  Eosinophilia is  the  hallmark of  helminthic 
infections, and occurs in dermatoses, bronchial asthma,  drug reactions, and  several 
other conditions grouped as the hypereosinophilic syndrome (5). 
The availability  of antisera against cells of the polymorphonuclear series, e.g., 
neutrophils  (6,  7),  has  greatly facilitated investigation  of  their function  and 
kinetics. Similar antisera have not  been  available previously for the  study of 
eosinophils, We have been attempting to produce an  antieosinophil serum for 
some time, but have failed because of the difficulty in obtaining pure prepara- 
tions  of  eosinophils  in  sufficient  quantity.  Recently  Colley  (8)  reported  a 
method  of producing an eosinophil-rich peritoneal exudate from mice infected 
with Schistosoma  mansoni.  The peritoneal exudate was purified by a  modifica- 
tion of the techniques described by Day (19) and Gleich and Leogering (10). To 
our knowledge this is the first communication  reporting  the  preparation  and 
characterization of a specific antieosinophil serum (AES). 
Materials and Methods 
Collection of EosinopMls.--Eosinophil-rich peritoneal exudates  were obtained from mice 8 
wk after exposure to 100 S.  mansoni cercariae (8). The peritoneal cavity was injected with 
1..5 ml of 10% proteose peptone (Difco Laboratories, Inc., Detroit, Mich.)  and 48 h later it 
was washed with 5 ml of Hanks' balanced salt solution  (Grand Island Biological Co., Grand 
Island, N. Y.)  containing 2.5 IU heparin/ml  (Upjohn  Co.,  Kalamazoo, Mich.).  A total of 
6  :/,  107  8  X  107 cells of which  55-78%  were eosinophils was  obtained from  each mouse. 
Exudates from  several mice were pooled,  layered over a  solution of Hypaque 50  (sodium 
diatrizoate USP,  Winthrop Laboratories, New York),  diluted 1:2 with distilled water, and 
centrifuged at 400 g for 40 rain at 4°C. Eosinophils collected from the pellet at the bottom of 
the centrifuge  tube were resuspended  in pyrogen-free saline, washed twice, and counted in a 
helnacytometer using Discombe's diluting fluid (11). 
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Preparation of AES.--Each of two adult male New Zealand albino rabbits weighing 4.5-5.0 
kg received three weekly subcutaneous injections, each consisting of 4  )<  108 cells averaging 
90.3% eosinophils,  5.8% maerophages, and 3.4% Iymphocytes suspended in 1 ml physiological 
saline and mixed with an equal amount of Freund's complete adjuvant  (Difco).  1 wk after 
the last injection the animals were bled and the sera pooled, inactivated at 56°C for 40 min, 
and stored frozen at -20°C until further use. 
Titration  of AES.--Agglutinating  titers of crude and purified AES against eosinophils, 
neutrophils,  macrophages, lymphocytes, and  red  cells  were  determined in  siliconlzed  test 
tubes by serial twofold dilutions from 1  ; 10 to 1  : 10,240 as described by Simpson and Ross (12). 
Absorption of AES.--Macrophages and lymphocytes were obtained from mouse peritoneal 
exudates (13). A 4 ml sample of pooled serum was absorbed twice for 1 h at 23°C and over- 
night at 4°C with 6 X  106 cells consisting of 75-80% macrophages and the remainder lympho- 
cytes.  The  absorbed serum  was  retested for  macrophage and  lymphocyte agglutination. 
Eosinophils were  obtained  as  described above;  neutrophils were  obtained  by  stimulating 
peritoneal exudates with 1.5 ml 10% proteose peptone for 18 h. Samples of 0.5 ml of AES were 
absorbed with 6 X  l0  T  neutrophils or eosinophils for 1 h at 23°C. The absorbed sera were then 
titrated against eosinophils. 
Cytotoxicity of A bsorbed A ES.--Cytotoxicity testing was carried out as described previously 
(13) using fresh guinea pig serum as a source of complement. 
In Fivo Activity oJ AES.--The effect of unabsorbed and absorbed AES on the peripheral 
eosinophil counts was compared to that of normal rabbit serum (NRS) on normal and schisto- 
some-infected mice.  Each animal received a  single  intraperitoneal dose of 0.1  ml of either 
serum. Absolute eosinophil,  total leukocyte, and differential counts were done before injection 
and at given intervals thereafter. 
Since the level of circulating eosinophils in normal mice is low,  the technique of Archer 
and Hirsch  (14) was used to stimulate exudation of eosinophils in the peritoneal cavity of 
normal mice. Three groups of five animals each were used: group 1 received 0.1 ml AES intra- 
peritoneally and group 2 a  similar dose of NRS before stimulation of the peritoneal cavity; 
the 3rd group was untreated. Saline  stimulation [5 ml of 0.85% NaC1 ip (intraperitoneally)] 
was done for 3 consecutive days and the animals were killed 30 rain after the last injection. 
The total eosinophil count of the peritoneal exudate was then determined. 
RESULTS 
Titration of AES.--The unabsorbed AES contained agglutinating antibodies 
to  eosinophils,  macrophages,  and lymphocytes.  The titers  were  1:5,120 for 
eosinophils,  1:80 for macrophages, and  1:20 for lymphocytes. The serum did 
not agglutinate either neutrophils or red cells in dilutions as low as 1 : 2. 
Absorption and Specificity of AES.--Agglutinins  against  macrophages  and 
lymphocytes were eliminated by two absorptions with 48 h peritoneal exudate 
cells. Absorbed monospecific AES retained the same agglutination titer against 
eosinophil  (1:5,120).  The  absorbed  AES  contained  cytotoxic  antibodies  to 
eosinophils in dilutions up to 1:5,120 as demonstrated by uptake of trypan blue 
by 50 % or more of the cells. 
Matched single absorptions of equal samples of AES with identical numbers 
of polymorphonuclear cells (either eosinophils or neutrophils) revealed that the 
eosinophils  reduced  the  eosinophil  agglutination  titer  from  1:5,120  to  1:80 
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Hematologic Response to AES  and NRS  in Normal  and Schistosome-lnfected 
Mice.- 
Normal mice: AES produced no significant change in the total white cell or 
differential counts in comparison with either animals that received NRS or un- 
treated controls (Table I). 
Mice with schistosomiasis  mansoni of 7  wk duration:  AES  caused a  drop  of 
peripheral eosinophils to  11.5% of their original level in 1 h  (Fig.  1).  Eosino- 
TABLE  I 
Effect of Intraperitoneal Administration of AES or NRS on Total and Differenlial While Cell 
Counts 24 h after Injection (Each Reading Represents a Mean q[ Five Animals) 
Total leukocyte  Differential leukocyte counts Mean -4-SE 
count/mm~ 
Mean +SE  Lymphocyte  Neutrophil  Monocyte  Eosinophil 
% 
AES  5,440  4-  717  71.6  4-  3.0  24.0  4-  3.0  4.4  4-  0.4  0 
NRS  6,468  4-  576  74.6  4-  1.3  19.0  4-  1.1  5.2  4-  0.5  1.2  4-  0.6 
Controls  5,976  4-  656  72.8  4-  1.7  21.2  4-  1.2  5.0  4-  0.8  1.0  4- 0.6 
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FIG.  1.  Effect  on the  absolute eosinophiI count  of  one  close  (0.1  ml)  of  AES  or  NRS  ad- 
ministered  intraperitoneally  to mice with  schistosomiasis mansoni of  7 wk duration.  Each 
point represents a mean of five animals. 
penia was maintained for 5 days, followed by a gradual recovery to near initial 
levels in 15  days.  NRS  had no significant effect on the  counts of circulating 
eosinophits. Except for a  slight and temporary drop  of total leukocyte count 
(11.9% at 12 h), probably related to the fall in eosinophils, AES effect was not 
significantly different from NRS  (Fig. 2). 
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saline, five animals previously injected with NRS, each produced an average of 
3.6  X  105 eosinophils/peritoneal cavity and five untreated controls 3.4  ;<  105 
eosinophils/peritoneal  cavity. Among the  five mice treated with AES  before 
peritoneal stimulation, three had no eosinophils in the exudate and the remain- 
ing two had approximately 5,000 cells each. 
DISCUSSION 
The  polymorphonuclear  eosinophil  remains  a  mystery; its  relation  to  the 
polymorphonuclear  neutrophil  and  its  role  in  immunological  reactions  are 
essentially unknown.  Eosinophils  are  believed  to  progress  through  the  same 
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FIG. 2.  Effect on the total white cell count of one dose (0.1 ml) of AES or NRS adminis- 
tered intraperitoneaUy to mice with schistosomiasis mansoni of 7 wk duration. Each point 
represents a mean of five  animals. 
maturation  sequence  as  neutrophils  (15).  The  granules,  which  are  the  most 
striking  feature  of  eosinophils,  begin  to  appear  at  the  promyelocyte  level. 
Nevertheless, the present study reveals complete antigenic individuality of the 
mouse eosinophil and neutrophil. AES markedly lowered circulating eosinophil 
counts in infected animals and also depressed the exudation of eosinophils in 
the peritoneal cavity of normal mice after saline stimulation. As the time re- 
quired for maturation of mouse eosinophils was calculated to be 32 h (16), and as 
AES-produced  eosinopenia was maintained for about 5  days,  the serum may 
have caused a maturation block or depletion of eosinophil precursor cells in the 
bone marrow. 
Blood eosinophilia is common in helminthic diseases,  and is often found in 
allergic  reactions  (17),  dermatoses,  and  occasionally in  so-called eosinophilic 
leukemia  (18).  Eosinophils  have  been  demonstrated  in  anaphylactic  (19), 
antigen-antibody complex (20), and cell-mediated granulomatous hypersensitiv- 1530  MAHMOUD  ET  AL.  BRIE:F  DE~'INITIVE REPORT 
ity  reactions  (21,  22).  Nevertheless,  their  immunological  function  remains 
obscure, as does their role in immunopathological processes. 
Availability of AES should facilitate elucidation of the relationship among 
the different types of polymorphonuclear cells,  the kinetics of eosinophils, the 
function of these cells, and their role in the pathogenesis of certain diseases. The 
specificity of AES suggests its use in treatment of eosinophilic diseases of long 
duration and unpredictable course such as eosinophilic pneumonitis or eosino- 
philic leukemia. 
SUMMARY 
Antieosinophil serum (AES), obtained by immunizing rabbits with a highly 
purified suspension of mouse eosinophils, contains high titers of specific agglu- 
tinating and cytotoxic antibodies to eosinophils. Absorption with macrophages, 
1}anphocytes, and neutrophils does not affect the antieosinophilic activity while 
it is markedly lowered by absorption with eosinophils. One dose of AES (0.1 nil) 
injected into mice with schistosomiasis mansoni caused a mean decrease in cir- 
culating  eosinophils  of  90%  within  1  h  which  was  maintained  for  5 
days, followed by gradual recovery. No other changes in the total or differential 
white cell counts were noted. In normal mice AES markedly depressed exuda- 
tion of eosinophils in  the peritoneal cavity after repeated saline  stimulation. 
Some of the immunological and clinical implications of a monospecific AES are 
discussed. 
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